Form D Explorer

Inspect source fieldsReport a record issue

Form D — Nok Therapeutics, Inc.

0001213900-26-034315 · filed Mar 26, 2026

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Check this disclosure on SEC EDGAR · More Biotechnology filings

Offering

Industry
Biotechnology
Exemptions
Rule 506(b)
Reported offering amount
$1,400
Reported amount sold
$1,400
Minimum investment
$100
Investors
—
Sales commission
—
Finders' fees
—

Issuer

Name
Nok Therapeutics, Inc.
CIK
2038166
Entity
Corporation
Jurisdiction
FLORIDA
Year incorporated
2024
Address
2009 MACKENZIE WAY
CRANBERRY TWP., Pennsylvania 16066
Phone
888-691-5839

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

Other filings from this issuer

View the original filing on SEC EDGAR ↗